At present, Organon & Co (OGN) has a stock price of $8.78. In the previous session, the stock saw a rise, peaking at $18.0 after an opening price of $8.81. The day’s lowest price was $10.0, and it closed at $9.67.
Organon & Co ‘s stock market performance has been somewhat erratic.
52-week price history of OGN Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Organon & Co’s current trading price is -61.97% away from its 52-week high, while its distance from the 52-week low is 9.66%. The stock’s price range during this period has spanned from $8.01 to $23.10. In the Healthcare sector, the Organon & Co’s shares surpassed a trading volume of approximately 5.77 million for the day, which was noticeably higher compared to the average daily volume of 9.4.92 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Organon & Co (OGN) has experienced a quarterly rise of 0.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.28B and boasts a workforce of 10000 employees.
A Closer Look at Analysts’ Ratings for Organon & Co
As of right now, 0 analyst is rating Organon & Co as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.82, with a change in price of -6.45. Similarly, Organon & Co recorded 5,097,929 in trading volume during the last 100 days, posting a change of -43.03%.
Examining OGN’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for OGN stands at 16.52. Similarly, the long-term debt-to-equity ratio is also 16.49.
OGN Stock Stochastic Average
Today’s raw stochastic average for Organon & Co over the last 50 days is 14.25%.This indicates a increase from the raw stochastic average of the past 20 days, which was 6.11%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 22.91% and 32.44%, respectively.
OGN Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -59.43%.However, over the last six months, we can see a stronger performance of -41.09%. Over the last 30 days, the price of OGN has leaped by -9.63%. And in the last five days, it has fallen by -13.37%.
